Cytokinetics
CYTK
#2398
Rank
โ‚ฌ6.67 B
Marketcap
54,60ย โ‚ฌ
Share price
-1.80%
Change (1 day)
19.93%
Change (1 year)

Market capitalization of Cytokinetics (CYTK)

Market cap: โ‚ฌ6.67 Billion

As of January 2026 Cytokinetics has a market cap of โ‚ฌ6.67 Billion. This makes Cytokinetics the world's 2398th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cytokinetics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ6.67 B1.63%
2025โ‚ฌ6.56 B22.29%
2024โ‚ฌ5.37 B-27.47%
2023โ‚ฌ7.40 B83.2%
2022โ‚ฌ4.04 B19.01%
2021โ‚ฌ3.39 B184.05%
2020โ‚ฌ1.19 B113.37%
2019โ‚ฌ0.56 B85.4%
2018โ‚ฌ0.30 B-17.41%
2017โ‚ฌ0.36 B-21.98%
2016โ‚ฌ0.46 B23.9%
2015โ‚ฌ0.37 B48.72%
2014โ‚ฌ0.25 B76.31%
2013โ‚ฌ0.14 B103.17%
2012โ‚ฌ71.07 M33.03%
2011โ‚ฌ53.43 M-49.18%
2010โ‚ฌ0.10 B-15.53%
2009โ‚ฌ0.12 B22.25%
2008โ‚ฌ0.10 B-36.23%
2007โ‚ฌ0.15 B-34.93%
2006โ‚ฌ0.24 B65.55%
2005โ‚ฌ0.14 B-26.94%
2004โ‚ฌ0.20 B

End of Day market cap according to different sources

On Jan 15th, 2026 the market cap of Cytokinetics was reported to be:

โ‚ฌ6.67 Billion
by Nasdaq info icon info icon
โ‚ฌ6.67 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚ฌ3.32 B-50.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
โ‚ฌ0 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚ฌ0.7 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ152.95 B 2,191.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚ฌ1.30 B-80.52%๐Ÿ‡บ๐Ÿ‡ธ USA